New questionnaire aims to give voice to women with chronic pelvic pain
NCT ID NCT06083597
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study involves 55 women with chronic pelvic pain to develop a questionnaire that captures their full experience. Researchers will interview participants to understand symptoms and impacts, then test the questionnaire for clarity and completeness. The goal is to create a reliable tool for future treatment studies, not to test a new therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 55 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2023
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Women with chronic pelvic pain (CPP) meeting the American College of Obstetricians and Gynecologists criteria.
- Ages
-
18 to 60 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
I. First phase of study evaluation women with presumed venous origin chronic pelvic pain Inclusion Criteria : 1. Non-menopausal women ≥18 years old. a. Women who are not menstruating because of ovarian suppression therapy for CPP are eligible. 2. CPP meeting the American College of Obstetricians and Gynecologists criteria. 3. Patient pain is primarily of pelvic and/or pelvic floor origin. Patient may experience other pain symptoms, including bowel, bladder, musculoskeletal, skin allodynia and hyperalgesia, or lower extremity venous or vulvar pain. 4. Imaging demonstrating multiple tortuous pelvic varicose veins \> 5 mm in diameter in the ovarian, utero vaginal, and/or uterine arcuate venous plexus. a. Imaging must be documented from trans vaginal ultrasound, trans abdominal ultrasound, magnetic resonance imaging, computed tomography, catheter venogram, or trans fundal pelvic venogram. If laparoscopic images are available to confirm veins this size, this would be acceptable as well. 5. Venous contribution to CPP, as determined by clinical impression from a CPP specialist. Clinical impression will be based on the presence of the following symptoms and physical findings: a. Symptoms: i. CPP increased with standing, walking, or lifting ii. CPP increased at the end of the day iii. CPP improved by laying down iv. Sexually provoked prolonged post-coital ache b. Physical findings: i. Adnexal tenderness on gentle bimanual exam ii. Tenderness at the ovarian point trans-abdominally iii. Tenderness of the uterus 6. Participant can read, communicate clearly, and understand English or Spanish. 7. Participant is willing and able to participate in an interview and complete questionnaires. 8. Participant is willing and able to provide informed consent. Exclusion Criteria: 1. Pain symptoms should primarily be of pelvic and/or pelvic floor origin (inclusion criteria #3 above). Pain should not be exclusively low back, hips, symphysis, allodynia or hyperalgesia of the skin, or from varicose veins of the vulvar and/or lower extremities. 2. Pain thought primarily to be due to endometriosis, pelvic floor myalgia, a musculoskeletal etiology, irritable bowel disease, or painful bladder syndrome/interstitial cystitis. 3. Obvious endometriosis based on physical exam or laparoscopy findings. 4. Patients previously treated with a technically successful surgery or vascular procedure for a venous disorder of the pelvis or renal vein. 5. Participant has any clinically relevant medical condition (e.g., severe co morbid condition, severe mental illness, severe visual or auditory impairment, or cognitive impairment) that, in the opinion of the investigator, would interfere with participating in an interview and/or completing the study procedures II. Second phase of study evaluation women with non-venous origin chronic pelvic pain Inclusion Criteria : 1. Non-menopausal women ≥18 years old. a. Women who are not menstruating because of ovarian suppression therapy for CPP are eligible. 2. CPP meeting the American College of Obstetricians and Gynecologists criteria. 3. Patient pain is primarily of pelvic and/or pelvic floor origin. Patient may experience other pain symptoms, including bowel, bladder, musculoskeletal, skin allodynia and hyperalgesia, or lower extremity venous or vulvar pain. 4. Imaging demonstrating multiple tortuous pelvic varicose veins \> 5 mm in diameter in the ovarian, utero vaginal, and/or uterine arcuate venous plexus. a. Imaging must be documented from trans vaginal ultrasound, trans abdominal ultrasound, magnetic resonance imaging, computed tomography, catheter venogram, or trans fundal pelvic venogram. If laparoscopic images are available to confirm veins this size, this would be acceptable as well. 5. Venous contribution to CPP, as determined by clinical impression from a CPP specialist. Clinical impression will be based on the presence of the following symptoms and physical findings: a. Symptoms: i. CPP increased with standing, walking, or lifting ii. CPP increased at the end of the day iii. CPP improved by laying down iv. Sexually provoked prolonged post-coital ache b. Physical findings: i. Adnexal tenderness on gentle bimanual exam ii. Tenderness at the ovarian point trans-abdominally iii. Tenderness of the uterus 6. Participant can read, communicate clearly, and understand English or Spanish. 7. Participant is willing and able to participate in an interview and complete questionnaires. 8. Participant is willing and able to provide informed consent. Exclusion Criteria: 1. Pain symptoms should primarily be of pelvic and/or pelvic floor origin (inclusion criteria #3 above). Pain should not be exclusively low back, hips, symphysis, allodynia or hyperalgesia of the skin, or from varicose veins of the vulvar and/or lower extremities. 2. Pain thought primarily to be due to endometriosis, pelvic floor myalgia, a musculoskeletal etiology, irritable bowel disease, or painful bladder syndrome/interstitial cystitis. 3. Obvious endometriosis based on physical exam or laparoscopy findings. 4. Patients previously treated with a technically successful surgery or vascular procedure for a venous disorder of the pelvis or renal vein. 5. Participant has any clinically relevant medical condition (e.g., severe co morbid condition, severe mental illness, severe visual or auditory impairment, or cognitive impairment) that, in the opinion of the investigator, would interfere with participating in an interview and/or completing the study procedures
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic pelvic pain syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Weill Cornell Medicine
New York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Nerve-Pain drug quiet chronic pelvic pain?
- Can measuring pelvic muscle function unlock the mystery of chronic pelvic pain?
- Could a smartphone app ease the agony of waiting for chronic pain treatment?
- Could a muscle relaxant suppository ease chronic pelvic pain?
- New study tracks pain relief for women with pelvic congestion syndrome
- New device aims to quiet pelvic pain without drugs